KMID : 0613820220320040318
|
|
Journal of Life Science 2022 Volume.32 No. 4 p.318 ~ p.324
|
|
Transcriptional Regulation of Lipogenesis and Adipose Expansion
|
|
Jang Young-Hoon
|
|
Abstract
|
|
|
PPAR¥ã and C/EBP¥á are master adipogenic transcription factors (TFs) required for adipose tissue development. They control the induction of many adipocyte genes and the early phase of adipogenesis in the embryonic development of adipose tissue. Adipose tissue continues to expand after birth, which, as a late phase of adipogenesis, requires the lipogenesis of adipocytes. In particular, the liver and adipose tissues are major sites for de novo lipogenesis (DNL), where carbohydrates are primarily converted to fatty acids. Furthermore, fatty acids are esterified with glycerol-3-phosphate to produce triglyceride, a major source of lipid droplets in adipocytes. Hepatic DNL has been actively studied, but the DNL of adipocytes in vivo remains not fully understood. Thus, an understanding of lipogenesis and adipose expansion may provide therapeutic opportunities for obesity, type 2 diabetes, and metabolic diseases. In adipocytes, DNL gene expression is transcriptionally regulated by lipogenesis coactivators, as well as by lipogenic TFs such as ChREBP and SREBP1a. Recent in vivo studies have revealed new insights into the lipogenesis gene expression and adipose expansion. Future detailed molecular mechanism studies will determine how nutrients and metabolism regulate DNL and adipose expansion. This review will summarize recent updates of DNL in adipocytes and adipose expansion in terms of transcriptional regulation.
|
|
KEYWORD
|
|
Adipose expansion, gene expression, lipogenesis, metabolism, nutrients
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|